Crawford Scientific Acquires Anatune Ltd
Crawford Scientific has announced the acquisition of Anatune Ltd.
Crawford Scientific has announced the acquisition of Anatune Ltd. Anatune Ltd will continue to operate as a separate legal and commercial entity while allowing Crawford Scientific customers access to Anatunes expertise in automation and trace analytical measurement.
“Over the many years we have known Ray Perkins and his team at Anatune, we have been impressed by their expertise in applications development for the most challenging analytical separations and their ability to automate these solutions,” said Tony Taylor, Group Technical Director, Crawford Scientific Holdings Ltd. “We welcome Ray and his team to the Crawford Scientific family and look forward to many successful collaborations with our clients.”
“Anatune becoming part of the Crawford Scientific Group means we can match the growing demand for automated sample preparation solutions. Both organizations are oriented around first-class technical support and have similar cultures and missions. We are excited by the new opportunities before us,” said Ray Perkins, CEO of Anatune.
The acquisition of Anatune Ltd follows Crawford Scientific’s acquisition of VR Analytical earlier in the year. Based out of Oregon, USA, VR Analytical partnered with Hall Analytical Laboratories in Manchester, UK, as part of the deal and offered clients extractables and leachables analysis, as well as, electronic nicotine delivery systems (ENDS).
“We are delighted to be joined by Ray Colton and his excellent team at VR Analytical, which presents exciting opportunities for our customers in this rapidly expanding and technologically challenging testing market,” commented Sam Crawford, Managing Director of Crawford Scientific Holdings Ltd.
For more information, please visit: www.crawfordscientific.com, www.anatune.com, or www.vranalytical.com
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
